Ivabridine is indicated in the management of
Refer kDT 6/e p 55,katzung 11e p203 Ivabradine is a bradycardia drug. It selectively blocks if sodium channel blocker and reduce hea rate by inhibiting the hyperpolarization activated sodium channel in the SA node. No other significant hemodynamic effects has been noted. It reduces and then attacked similar to Calcium channel blocker and beta blockers
PSVT
Angina pectoris
Cardiomyopathy
Irritable bowel syndrome
Cardiovascular system